Author Guidelines
1. Aims and Scope
Histopathology is an international journal that publishes high quality research from a broad range of areas within the field of diagnostic human pathology. This includes papers in which the research is solely based on morphological/histopathological techniques and those in which these are complemented by or integrated with other methods and technologies such as proteomics and genomics. There is a focus on papers in which there is a clear impact on clinical outcomes including improved diagnosis and prediction of response to therapies (tissue based personalized medicine). The journal also publishes papers that describe technical innovations that lead to improved diagnostic and prognostic information such as digital pathology and artificial intelligence. Purely prognostic papers will only be considered if they can demonstrate a clear clinico-pathological justification with a multivariate analysis comparing all known parameters.
Translational studies with direct relevance to the interpretation of tissue and cellular alterations in human disease are also welcome although the journal does not accept papers that are solely based on animal or tissue culture studies.
As well as original research papers, the Journal seeks to provide rapid publication in a variety of other formats, including editorials, review articles (both contributed and solicited), short reports, lessons of the month and Correspondence. The journal will consider high quality systematic reviews and where appropriate meta-analyses of relevant data.
Case reports
These are published only as 'Correspondence' or 'Lessons of the Month' and must be of marked originality and have an exceptionally important clinical and pathological message.
As the journal of the British Division of the International Academy of Pathology, it seeks to reflect the broad professional interests of the Society’s membership but its ethos, authorship, content and purpose are those expected of a leading publication in the international scientific literature.
2. Submitting your Manuscript: Summary
The average time from submission to first decision is usually within three weeks.
Please make your submission online at http://mc.manuscriptcentral.com/histop.
Submissions can be uploaded as a Word document plus separate figure files (GIF, JPG, BMP, TIF, PIC).
Should you experience any difficulties in submitting your manuscript, please do not hesitate to contact the Editorial Assistant whose contact details are as follows:
Histopathology Editorial Office
E-mail: HISedoffice@wiley.com
The following outlines the requirements for submission of a manuscript to Histopathology. Further details are given below. There are no submission charges, page charges or fees for inclusion of supporting information on the internet.
Every manuscript should have:
A concise cover letter
A Microsoft Word (or equivalent) file (NOT A PDF) that is presented in English, in a double spaced format using a standard font (e.g. Arial, Helvetica, Times Roman etc 12 point) and has page numbers
A title page (or pages) containing:
• A succinct and clear title that accurately describes the work contained within the manuscript.
• A short running title (up to 50 characters including spaces)
• List of authors (using given and family name, but not degrees)
• Full affiliations of all authors and contact details of the corresponding author(s)
• A conflict of interest statement
• A word count (from beginning of Introduction to end of Discussion)
The next page should have:
• An Abstract (structured and no more than 250 words)
• Keywords (3 to 8) preferably chosen from the medical subject headings (MeSH) in Index Medicus.
The manuscript should contain the following:
• Introduction
• Materials and methods
• Results
• Discussion
• Acknowledgements which should include a statement defining funding sources
• List of abbreviations (optional)
• List of online Supporting Information (if any)
• Reference list in the correct format (see below)
• Table(s)
• Figure legends (concise and not repeating material in the Results section)
As separate files:
• Figures (at the appropriate size and resolution [http://authorservices.wiley.com/electronicartworkguidelines.pdf])
• Supporting Information files (if any)
• Additional Files for Review but NOT for publication
• Patient Consent Form (where relevant)
2.1 Submission Checklist
The manuscript must be submitted via the online submission system (and not by mail or email), which is located at: http://mc.manuscriptcentral.com/histop
• Your Histopathology Manuscript Central username and password (unless you are a new user)
• All manuscript, figure and Supporting Information files finalised and ready to upload
• Permission to reproduce any previously published material scanned and ready to upload
• Full correct names and E-mail addresses of all of your co-authors.
• The names and full contact details of up to three suggested referees
• Additional files for review but not for publication may be provided
Our helpful guide will make your paper more discoverable with Search Engine Optimization.
Data Sharing and Data Accessibility
Histopathology recognizes the many benefits of archiving research data. Histopathology expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles https://www.force11.org/group/fairgroup/fairprinciples. All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Authors will be required to confirm adherence to the policy. If you cannot share the data described in your manuscript, for example for legal or ethical reasons, or do not intend to share the data then you must provide the appropriate data availability statement. Histopathology notes that FAIR data sharing allows for access to shared data under restrictions (e.g., to protect confidential or proprietary information) but notes that the FAIR principles encourage you to share data in ways that are as open as possible (but that can be as closed as necessary). Sample statements are available here. If published, all statements will be placed in the heading of your manuscript.
2.2 Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
2.3 Review Process
An initial assessment will be made by the Editor-in-Chief (or one of three Regional Editors) following submission of your manuscript. This process considers whether the submitted work falls within the scope of Histopathology (see above) and is of initial interest and/or scientific worth to merit possible publication. At this point a proportion of manuscripts will be returned to the authors.
Manuscripts that enter the review process are assigned sequentially to a relevant Associate Editor who invites reviewers (normally two external reviews are sought). The reviewers’ evaluations and Associate Editor’s comments are submitted to the Editor-in-Chief (or the relevant Regional Editor) to inform a final decision. We aim to convey a decision within four weeks of the receipt of the manuscript.
The Editor-in-Chief or Regional Editor will advise authors whether a manuscript is accepted, requires revision, or is rejected. Revisions are expected to be returned within four weeks of decision. Manuscripts not revised within this time are subject to withdrawal from consideration for publication unless there are extenuating circumstances.
Please note that some manuscripts will have to be rejected on the grounds of priority, interest, journal balance and available space. Invitation to submit a revised manuscript does not imply that acceptance will automatically follow.
Authors may provide the Editor-in-Chief /Regional Editors with the names, addresses and email addresses of up to three suitably qualified individuals of international standing who would be competent to referee the paper, although the Editorial team will not be bound by any such nomination. Likewise, authors may advise of any individual who for any reason, such as potential conflict of interest, might be inappropriate to act as a referee, again without binding the Editor-in-Chief.
The decision of the Editor-in-Chief is final. If, however, authors dispute a decision and can document good reasons why a manuscript should be reconsidered, a rebuttal process exists. In the first place, authors should write to the Editor-in-Chief outlining their case.
Detailed guidance on the preparation of manuscripts:
Cover-letter
Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. This should be confirmed in the covering letter. The corresponding author must confirm that all authors have agreed with the submission in its present (and subsequent) forms. The authors should also indicate in their covering letter: the aim of the study; the significant and novel findings and where relevant how the findings could influence clinical practice.
General points
The manuscript should be prepared using a word processing package, using a standard font, double spaced with margins of at least 2 cm and have page numbers. Do not use line numbering. The manuscript should be in English using consistent and preferably UK spelling.
Manuscript title
The title of the paper should be short and must summarise the content of the article. It should be presented in a way that catches the attention of readers. It must however be accurate and unambiguous and should focus on the message of the paper.
Short running title
This should be concise (maximum of 50 characters including spaces) and reflect the main title and content of the manuscript. The running title is often used on the journal front cover, so please consider the running title’s effectiveness for this purpose seriously when submitting.
List of contributors
All those designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One author (deemed to be the Corresponding Author) should take responsibility for the integrity of the work as a whole, from inception to published article. Joint first authorship is permitted but this is normally restricted to two contributors unless there are exceptional circumstances.
Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Provision of funding, collection of data or general supervision of the research group alone does not justify authorship. All others who contributed to the work who are not authors should be named in an Acknowledgements section.
If you are submitting a revised article and the authors have changed from the original submission, for example: if additional authors are added [or removed] then agreement of all authors is mandatory with justification and explanation required within the covering letter, submitted via the ScholarOne system.
Full affiliations of all authors
This should include the name of the department(s) and institution(s) to which the work should be attributed, and contact details of the corresponding author i.e. the full postal address, phone number and email address.
Conflict of interest statement
Authors are responsible for disclosing all financial and personal relationships between themselves and others that might bias their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. Authors should describe the role of the study sponsor(s), if any, in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the report for publication.
A conflict of interest statement must be included in the manuscript (on the title page) that details any conflicts that exist for each author, or declares the absence of conflict for each author; this will be incorporated into the text of any accepted article.
We provide here details of some example situations or arrangements that the Editors of Histopathology would deem to result in a conflict of interest:
• Private or corporate funding of any part of the study, or donation or loan of supplies or equipment. In such cases role of the study sponsor or donor(s), if any, in the study design; data collection, analysis or interpretation; or writing of the report must be made clear.
• For each author (or their immediate family members):
• Employment by a company that produces a material or equipment used in the study.
• The receipt of financial or other compensation (such as cash, travel/accommodation costs, royalties, fees, stock or stock options) for work; advising or consulting; expert testimony or advocacy/public speaking from companies, organizations, institutions, and individuals.
• The ownership of financial holdings or considerations, such as stocks or bonds in a company that could be construed as gaining from the conclusions of the study.
• The holding of a patent on a method or equipment used in the study, or that employs a principle validated by the study.
• The presence of personal, professional, political, institutional, religious, or other associations that could have a bearing upon the stance taken in the submitted work.
Full details of the conflicts of interest of our Editor-in-Chief, Regional Editors and Associate Editors are held on record at the journal offices.
We ask our Editors to identify any manuscripts for which there is a real or perceived conflict of interest; they would not participate in the review process in such a situation. Similarly we ask reviewers to similarly declare any conflict of interest and decline invitations to review if this exists.
With regard to conflict of interest we are guided by the principles laid down by the Committee on Publication Ethics (http://www.publicationethics.org.uk), the International Committee of Medical Journal Editors (Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication Updated October 2008 http://www.icmje.org/#conflicts ) and the World Association of Medical Editors (WAME Editorial Policy and Publication Ethics Committees Conflict of Interest in Peer-Reviewed Medical Journals Posted March 27, 2009. http://www.wame.org/conflict-of-interest-in-peer-reviewed-medical-journals).
Word count (From beginning of Introduction to end of Discussion)
The length of the manuscript should normally be no more than 2500 words. The use of online Supporting Information as a route for presenting additional material is available. When using the device of Supporting Information for additional text or data, authors should remember that the main manuscript must contain sufficient information to make the work intelligible without resort to the Supporting Information. For example, it is not acceptable to shorten a manuscript by placing all of the Materials and Methods in Supporting Information. However it is acceptable to place some aspects of experimental detail in Supporting Information.
Abstract (Structured and no more than 250 words)
After the title page(s) the next page should carry an abstract of no more than 250 words which includes subsections: Aims; Methods and results; Conclusions. The abstract should be concise and clear. It should emphasise new and important aspects of the study. It should be understandable without reference to the rest of the paper and should contain no citation to references in the reference list. Non-standard abbreviations should be avoided. Advice on how to optimise your abstract for search engines can be found here.
Keywords
Below the abstract, authors should provide and identify as such 3 to 8 keywords or short phrases to assist indexing the article and that may be published with the abstract. MESH headings are a useful guide for authors in considering keywords.
Manuscript structure: general aspects
As noted above full articles should usually be no more than 2500 words from the beginning of the Introduction to the end of the Discussion, which is approximately nine journal pages, when tables, figures and references are also included.
Review articles may exceed these limits by arrangement with the Editor-in-Chief. Please remember that succinct articles are likely to make a greater impact on readers than long ones and are likely to proceed more rapidly though the editorial process post-acceptance..
The text of research articles should be divided into sections with the headings: Abstract, Introduction, Methods, Results and Discussion. Some articles may need subheadings within sections (especially the Results and Discussion sections) to clarify their content. Such sections however should not be numbered.
Other types of articles, such as reviews and short reports, still need a title and abstract and should adhere as closely as possible to these guidelines. This is not required in Correspondence.
Review articles and editorials have greater flexibility than standard original articles although a concise clear style is essential. Such articles are usually by invitation although the editorial team is happy to receive suggestions and outlines of possible material of this kind. All such material, whether invited or not, will normally undergo peer review.
Editorials usually take the form of a brief (typically 2 to 3 journal pages) review that places a paper (or group of papers) published in the issue into a broader context. They should be focussed and pithy. They should be accessible to a broader audience than the primary papers might be. Diagrams are often useful to illustrate concepts and ideas.
Review Articles: The nature of a review article is self-explanatory. These might be of variable length from short items (mini-review) through to very detailed, fully referenced contributions.
Correspondence: Case reports, comments on previously published papers, items of topical interest, and brief original communications will be considered under this heading. The letter should not be divided into sections. No abstract is required. The length, including references, should be between 600 and 800 words. You should include no more than six references. Submit no more than two black and white or coloured illustrations; each should not exceed one column width. Case reports are only accepted as ‘Correspondence’ or ‘Lesson of the month’ and have to be of exceptional clinic-pathological interest.
Short reports: The Journal will consider brief original reports; the length should not exceed 1500 words. It should still include a structured abstract of 250 words. It should not contain more than two figures or tables, or one of each.
Lesson of the Month: Articles submitted for “Lesson of the Month” should be succinct with a punchy title and provide novel information to the reader. Such articles might include a description of a case (or cases) that raises interesting diagnostic issues from which an important lesson is learnt. This may include cases where errors have been made. Examples could include cases where there is a differential diagnosis and a particular immunostain is misleading or the description of a previously unreported iatrogenic artefact. No abstract is required. The length, including references, should be between 600 and 800 words. You should include no more than six references. Submit no more than two black and white or coloured illustrations; each should not exceed one column width.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/13652559/homepage/forauthors.html
